» Articles » PMID: 34015163

Impact of Prostatic Radiation Therapy on Bladder Contractility and Innervation

Overview
Date 2021 May 20
PMID 34015163
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Aims: To determine the effect of prostatic radiation therapy (RT) on bladder contractility and morphology, and axon, or neuron profiles within the detrusor and major pelvic ganglia (MPG) in male rats.

Methods: Male Sprague-Dawley rats (8 weeks) received a single dose of prostatic RT (0 or 22 Gy). Bladders and MPG were collected 2- and 10-weeks post-RT. Detrusor contractile responses to carbachol and electrical field stimulation (EFS) were measured. Bladders were stained with Masson's trichrome, and antibodies for nonspecific neuronal marker, cholinergic nerve marker choline acetyltransferase (ChAT), and alpha-smooth muscle actin. MPG gene expression was assessed by quantitative polymerase chain reaction for ubiquitin carboxy-terminal hydrolase L1 (Uchl1) and Chat.

Results: At 2 weeks post-RT, bladder smooth muscle, detrusor cholinergic axon profiles, and MPG Chat gene expression were increased (p < .05), while carbachol and EFS-mediated contractions were decreased (p < .05). In contrast, at 10 weeks post-RT, nerve-mediated contractions were increased compared with control (p < .05), while bladder smooth muscle, detrusor cholinergic axon profiles, MPG Chat expression, and carbachol contractions had normalized. At both 2- and 10-weeks post-RT, there was no change in detrusor nonspecific axon profiles and MPG Uchl1 expression.

Conclusion: In a rat model, RT of the prostate and MPG was associated with early changes in MPG Chat gene expression, and bladder cholinergic axon profiles and smooth muscle content which resolved over time. After RT recovery, bladder contractility decreased early and increased by 10 weeks. Long-term changes to the MPG and increased bladder cholinergic axons may contribute to RT-induced bladder dysfunction in prostate cancer survivors.

Citing Articles

Preclinical Female Model of Urogenital Dysfunction and Pathophysiological Changes After Pelvic Radiation Therapy.

Peters B, Powers S, Burleson L, Odom M, Pak E, Turner A Cureus. 2024; 16(8):e66374.

PMID: 39246936 PMC: 11379420. DOI: 10.7759/cureus.66374.


Recurrent infections drive persistent bladder dysfunction and pain via sensory nerve sprouting and mast cell activity.

Hayes B, Choi H, Rathore A, Bao C, Shi J, Huh Y Sci Immunol. 2024; 9(93):eadi5578.

PMID: 38427717 PMC: 11149582. DOI: 10.1126/sciimmunol.adi5578.


Effects of Microbeam Irradiation on Rodent Esophageal Smooth Muscle Contraction.

Frerker B, Fiedler S, Kirschstein T, Lange F, Porath K, Sellmann T Cells. 2023; 12(1).

PMID: 36611969 PMC: 9818134. DOI: 10.3390/cells12010176.

References
1.
Nascimento-Goncalves E, Faustino-Rocha A, Seixas F, Ginja M, Colaco B, Ferreira R . Modelling human prostate cancer: Rat models. Life Sci. 2018; 203:210-224. DOI: 10.1016/j.lfs.2018.04.014. View

2.
Mahmood J, Connors C, Alexander A, Pavlovic R, Samanta S, Soman S . Cavernous Nerve Injury by Radiation Therapy May Potentiate Erectile Dysfunction in Rats. Int J Radiat Oncol Biol Phys. 2017; 99(3):680-688. DOI: 10.1016/j.ijrobp.2017.06.2449. View

3.
Koontz B, Verhaegen F, De Ruysscher D . Tumour and normal tissue radiobiology in mouse models: how close are mice to mini-humans?. Br J Radiol. 2016; 90(1069):20160441. PMC: 5605019. DOI: 10.1259/bjr.20160441. View

4.
Yoshimura N, Chancellor M . Neurophysiology of lower urinary tract function and dysfunction. Rev Urol. 2006; 5 Suppl 8:S3-S10. PMC: 1502389. View

5.
Kibel A, Ciezki J, Klein E, Reddy C, Lubahn J, Haslag-Minoff J . Survival among men with clinically localized prostate cancer treated with radical prostatectomy or radiation therapy in the prostate specific antigen era. J Urol. 2012; 187(4):1259-65. DOI: 10.1016/j.juro.2011.11.084. View